시장보고서
상품코드
1755439

안과용 점탄성 기기 시장 규모, 점유율, 성장 분석, 제품 유형별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)

Ophthalmic Viscoelastic Devices Market Size, Share, and Growth Analysis, By Product Type, By Application, By End User, By Region-Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 197 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

안과용 점탄성 기기 세계 시장 규모는 2023년에 105억 달러, 2024년 117억 2,000만 달러에서 2032년에는 281억 9,000만 달러로 성장하고, 예측 기간(2025-2032년) CAGR은 11.6%를 나타낼 전망입니다.

안과용 점탄성 기기(OVDs) 시장은 백내장, 녹내장, 노인성 황반변성 등 안과 질환의 유병률 증가에 힘입어 강력한 성장세를 보이고 있습니다. 최소침습적 안과 수술에 대한 수요 증가와 점탄성 소재의 개발이 시장 확대의 원동력이 되고 있으며, OVD는 수술 시 공간 확보, 조직 안정화, 시력 저하를 방지하는 중요한 역할을 합니다. 전 세계 안과 수술의 급증, 의료 접근성 향상, 안과 질환에 대한 인식이 높아짐에 따라 시장이 성장할 것으로 예측됩니다. 또한, 특히 복잡한 안과 수술에서 여러 개의 주사기가 필요 없는 효율성으로 인해 점도 적응형 OVD의 채택이 증가하고 있습니다. 전반적으로 이러한 요인들이 산업을 발전시키고 있습니다.

목차

서론

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차와 1차 데이터 방법
  • 시장 규모 예측
  • 시장 전제조건과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porter의 Five Forces 분석

주요 시장 인사이트

  • 중요 성공 요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석

안과용 점탄성 기기 시장 규모 : 제품 유형별&CAGR(2025-2032년)

  • 시장 개요
  • 소수성
  • 친수성
  • 편성

안과용 점탄성 기기 시장 규모 : 유형별&CAGR(2025-2032년)

  • 시장 개요
  • 점착성 안과용 점탄성 물질
  • 분산성 안과용 점탄성 물질

안과용 점탄성 기기 시장 규모 : 성분별&CAGR(2025-2032년)

  • 시장 개요
  • 히알루론산 나트륨
  • 콘드로이친 황산
  • 하이드록시 프로파일 메틸 셀룰로오스

안과용 점탄성 기기 시장 규모 : 용도별&CAGR(2025-2032년)

  • 시장 개요
  • 백내장 수술
  • 각막 수술
  • 녹내장 수술
  • 굴절 교정 수술

안과용 점탄성 기기 시장 규모 : 최종사용자별&CAGR(2025-2032년)

  • 시장 개요
  • 병원
  • 외래수술센터(ASC)
  • 안과 클리닉

안과용 점탄성 기기 시장 규모 : 제형 유형별&CAGR(2025-2032년)

  • 시장 개요
  • 일회용
  • 다목적

안과용 점탄성 기기 시장 규모&CAGR(2025-2032년)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채택한 전략
  • 최근 시장 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업 개요
    • 기업 상세
    • 제품 포트폴리오 분석
    • 기업 부문별 점유율 분석
    • 매출 전년대비 비교(2022-2024년)

      주요 기업 개요

      • Alcon(스위스)
      • Bausch+Lomb(Bausch Health)(미국)
      • Carl Zeiss Meditec AG(독일)
      • Johnson & Johnson Vision(미국)
      • Rayner Intraocular Lenses Limited(영국)
      • Bohus BIoTech AB(스웨덴)
      • Lifecore Biomedical LLC(미국)
      • Hoya Corporation(일본)
      • Santen Pharmaceutical Co., Ltd.(일본)
      • Croma-Pharma GmbH(오스트리아)
      • Eyekon Medical Inc.(미국)
      • RUMEX International Co.(미국)
      • Ziemer Ophthalmic Systems AG(스위스)
      • Ophtechnics Unlimited(인도)
      • Haohai Biological Technology(중국)
      • Amring Pharmaceutical Inc.(미국)
      • Truviz Ophthalmic(미국)
      • Cima Technology Inc.(미국)

결론과 제안

LSH 25.07.01

Global Ophthalmic Viscoelastic Devices Market size was valued at USD 10.5 billion in 2023 and is poised to grow from USD 11.72 billion in 2024 to USD 28.19 billion by 2032, growing at a CAGR of 11.6% during the forecast period (2025-2032).

The ophthalmic viscoelastic devices (OVDs) market is experiencing robust growth fueled by the rising prevalence of eye disorders, including cataracts, glaucoma, and age-related macular degeneration. Increasing demand for minimally invasive eye surgeries, along with advancements in viscoelastic material formulations, is driving this expansion. OVDs play a vital role during surgeries by preserving space, stabilizing tissues, and preventing vision loss. With a surge in ophthalmic surgeries worldwide, improved access to care, and heightened awareness of ocular disorders, the market is set to thrive. Furthermore, the adoption of viscoadaptive OVDs is gaining traction, particularly in complex ocular procedures, due to their efficiency in reducing the need for multiple syringes. Overall, these factors are collectively propelling the industry forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ophthalmic Viscoelastic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ophthalmic Viscoelastic Devices Market Segments Analysis

The ophthalmic viscoelastic devices market is segmented into product type, application, end user and region. Based on product type, the market is segmented into cohesive ophthalmic viscoelastic and dispersive ophthalmic viscoelastic. Based on application, the market is segmented into cataract, glaucoma, corneal transplant and vitreoretinal surgery. Based on end user, the market is segmented into hospitals, ophthalmic clinics and others. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market is being significantly propelled by the rising occurrence of various eye disorders, including cataracts, glaucoma, and age-related macular degeneration, which correlate closely with an aging demographic and changing lifestyle choices. These conditions frequently require surgical treatments, underscoring the importance of ophthalmic viscoelastic devices that safeguard the eye's sensitive tissues, preserve surgical space, and enhance the overall surgical experience. As the patient population seeking such interventions increases, there is a correspondingly higher demand for superior viscoelastic products, thereby driving the market's growth and presenting opportunities for innovation in this critical healthcare segment.

Restraints in the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market faces a notable challenge due to the high costs associated with advanced devices that utilize innovative materials and improved biocompatibility. This elevated pricing poses a substantial obstacle for hospitals and clinics, particularly in emerging markets or areas with constrained healthcare budgets. As a result, patients in low and middle-income countries often encounter difficulties in accessing these premium products, primarily due to affordability concerns. Consequently, this situation restricts the overall market penetration of advanced ophthalmic viscoelastic devices in these regions, limiting their widespread adoption and use in vital eye care procedures.

Market Trends of the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market is witnessing a significant trend towards the integration of artificial intelligence (AI) and digital technologies within surgical workflows. This innovation is enhancing preoperative planning, intraoperative guidance, and postoperative care, particularly in the application of viscoelastic devices. As AI-driven imaging and surgical assistance become more sophisticated, they offer improved precision and reduced risks during procedures, which in turn leads to better surgical outcomes. This synergy is driving increased adoption rates of viscoelastic devices that are compatible with advanced AI systems, positioning the market for robust growth as these technologies become standard in ophthalmic surgery.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Ophthalmic Viscoelastic Devices Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Hydrophobic
  • Hydrophilic
  • Combination

Global Ophthalmic Viscoelastic Devices Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Cohesive Ophthalmic Viscoelastic
  • Dispersive Ophthalmic Viscoelastic

Global Ophthalmic Viscoelastic Devices Market Size by Composition & CAGR (2025-2032)

  • Market Overview
  • Sodium Hyaluronate
  • Chondroitin Sulfate
  • Hydroxypropyl Methylcellulose

Global Ophthalmic Viscoelastic Devices Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Cataract Surgery
  • Corneal Surgery
  • Glaucoma Surgery
  • Refractive Surgery

Global Ophthalmic Viscoelastic Devices Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers
  • Ophthalmic Clinics

Global Ophthalmic Viscoelastic Devices Market Size by Formulation Type & CAGR (2025-2032)

  • Market Overview
  • Single-Use
  • Multi-Use

Global Ophthalmic Viscoelastic Devices Market Size & CAGR (2025-2032)

  • North America (Product Type, Type, Composition, Application, End User, Formulation Type)
    • US
    • Canada
  • Europe (Product Type, Type, Composition, Application, End User, Formulation Type)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Type, Composition, Application, End User, Formulation Type)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Type, Composition, Application, End User, Formulation Type)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Type, Composition, Application, End User, Formulation Type)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Alcon (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bausch + Lomb (Bausch Health) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carl Zeiss Meditec AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson Vision (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rayner Intraocular Lenses Limited (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bohus Biotech AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lifecore Biomedical LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hoya Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Santen Pharmaceutical Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Croma-Pharma GmbH (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eyekon Medical Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RUMEX International Co. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ziemer Ophthalmic Systems AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ophtechnics Unlimited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Haohai Biological Technology (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amring Pharmaceutical Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Truviz Ophthalmic (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cima Technology Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제